Job Type:
Temporary, BenefitedPreferred Qualifications:
The preferred candidate will have previous experience in the following:
-Apheresis or donor center procedures.
- Critical care and blood product transfusions.
- Blood collection facility with strong phlebotomy skills.
- 3-5 years experience, ideally in an outpatient infusion center, hematology/oncology clinic or procedural care environment.
Equal Employment Opportunity Statement
Roswell Park Cancer Institute Corporation (RPCIC) and Health Research Inc. (HRI) Roswell Park Division believe that all persons are entitled to equal employment opportunities, and we do not discriminate against our employees, applicants or job seekers because of their race, color, religion, sex, sexual orientation, gender identity or expression, national origin, creed, age, disability, pregnancy-related condition, military or veteran status, marital or familial status, domestic violence victim status, citizenship status, genetic information, individual’s relationship or association with a member of a protected category or any other protected group status as defined by law.
Reasonable Accommodation Request
RPCIC and HRI are committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the employment process, please email [email protected] and let us know the nature of your request and your contact information.
Our Core Values
RPCIC and HRI are committed to providing an environment where patients, families, employees and community are treated with courtesy and respect. We support an inclusive environment that nurtures the talents, skills and abilities of each individual to embody and reflect our core values: Innovation, Integrity, Teamwork, Commitment, Compassion and Respect.
Historical Compensation Information Statement
Pursuant to Executive Order 161, no State entity, as defined by the Executive Order, is permitted to ask, or mandate, in any form, that an applicant for employment provide his or her current compensation, or any prior compensation history, until such time as the applicant is extended a conditional offer of employment with compensation. If such information has been requested from you before such time, please contact the Governor’s Office of Employee Relations at (518) 474-6988 or via email at [email protected].
Roswell Park Comprehensive Cancer Center brings together laboratory research, clinical care, and education in a multidisciplinary environment to advance cancer treatment. Researchers and clinicians work side by side to translate laboratory findings into patient therapies and contribute to ongoing trials, with historical breakthroughs in chemotherapy, photodynamic therapy, and PSA testing. It differentiates itself as the world’s first cancer-focused laboratory, operates as a public benefit corporation owned by New York State, and relies on grants and donations through affiliated nonprofits. The center’s goal is to conquer cancer by coordinating research, clinical care, and education to improve patient outcomes and scientific knowledge.
Company Size
1,001-5,000
Company Stage
Grant
Total Funding
$71.1M
Headquarters
Buffalo, New York
Founded
1898
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Roswell Park earns national AMA Joy in Medicine recognition for advancing physician well-being. Monday, October 12, 2026 - 09:00 am Prestigious 2026 designation recognizes Roswell Park's commitment to reducing physician burnout, strengthening resilience and enhancing the quality of patient care Highlights * AMA honors Roswell Park for advancing physician well-being * Recognition highlights efforts to reduce burnout and build resilience * Supportive workplace initiatives help caregivers and patients thrive BUFFALO, N.Y. - Roswell Park Comprehensive Cancer Center has earned national recognition in 2026 from the American Medical Association (AMA) as a Joy in Medicine(R) organization. The prestigious recognition from the country's leading physician association honors health systems, hospitals, and medical groups that prioritize proven methods to reduce burnout and enhance the professional fulfillment of doctors that comes from patient care. Organizations that meet the rigorous criteria of the Joy in Medicine Health System Recognition Program are leaders in the national effort to transform health care work systems and address the root causes of burnout among care teams. "We're honored to see Roswell Park's Resiliency resources recognized by AMA because we've seen the difference these supports make for our teams and for our patients," says Amy Case, MD, FAAHPM, who is the Lee Foundation Endowed Chair of the Department of Palliative and Supportive Care at Roswell Park. "Caring for the caregivers and attending to their needs is a critical part of exceptional healthcare, and Joy in Medicine has been a great framework for us to build our programming around." "This recognition is a testament to the culture our teams have built together," says Amy Gallagher, PsyD, MSHCT, from Roswell Park's Department of Supportive and Palliative Care. "We are committed to supporting our physicians not only as healthcare professionals, but as people. Prioritizing well-being helps us sustain excellence in patient care, strengthen collaboration and ensure our workforce remains resilient for the future." Since its inception in 2019, the AMA Joy in Medicine Health System Recognition Program has recognized more than 250 organizations across the country. Recognition levels are valid for two years. This year, a total of 92 health organizations nationwide earned recognition with documented efforts to reduce system-level drivers of work-related burnout and demonstrated competencies in commitment, assessment, leadership, efficiency of practice environment, teamwork, and support. Organizations that earned 2026-2027 recognition join a strong group of currently recognized organizations from the 2025-2026 program, bringing the currently recognized cohort to 194 recognized organizations. From the world's first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide. The Roswell Park team of 4,000+ makes compassionate, patient-centered cancer care and services accessible across New York State and beyond. Rated "Exceptional" by the National Cancer Institute, Roswell Park, founded in 1898, was one of the first NCI-designated comprehensive cancer centers in the country and remains the only one in Upstate New York. To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit www.roswellpark.org, call 1-800-ROSWELL (1-800-767-9355) or email [email protected]. Media Contact
Roswell Park Comprehensive Cancer Center and Generate Biomedicines have dosed the first patient in a clinical trial evaluating GB-5267, an investigational CAR T-cell therapy for ovarian cancer. The treatment targets MUC16, a biomarker over-expressed in more than 80% of ovarian tumours. GB-5267 is engineered with AI to optimise T-cell function in solid tumours. The therapy is "armored" with IL-18, a cytokine designed to protect T cells from the suppressive tumour microenvironment. It will be delivered both intravenously and into the peritoneal cavity. The phase 1 trial, led by Dr Emese Zsiros at Roswell Park, is recruiting patients whose ovarian cancer has returned after treatment or does not respond to platinum-based chemotherapy. Unlike many CAR T-cell approaches, this study does not require pre-infusion chemotherapy.
Roswell Park recognizes team members driving Excellence in cancer care and research. Thursday, September 24, 2026 - 10:00 am Second annual Excellence Awards spotlight exceptional employees whose work is shaping the future of oncology Highlights * Honorees include physicians, researchers and an advanced practice provider * Six winners selected from nearly 70 peer-nominated team members * Recognized for advancing cancer care, research and patient experience BUFFALO, N.Y. - Roswell Park Comprehensive Cancer Center recognized outstanding members of its clinical, research and healthcare teams during the second annual Excellence Awards, celebrating individuals whose contributions advance the organization's mission of delivering world-class cancer care, groundbreaking research and exceptional patient experiences. All winners were nominated by their colleagues at Roswell Park. "These award recipients represent the very best of Roswell Park," says Julia Faller, DO, MS, Chief Medical Officer at Roswell Park Comprehensive Cancer Center. "Through their dedication to patients, commitment to scientific discovery, focus on quality and safety, and willingness to collaborate across disciplines, they are helping shape the future of cancer care while making a meaningful difference in the lives of patients and families every day." All 67 nominees across six different award categories were recognized on Thursday, Sept. 10. The six finalists who were presented with awards at that evening event: Since joining Roswell Park in 2013, Dr. Petroziello has helped transform interventional radiology services, establishing a nationally recognized liver radiation program that ranks among the top five in the country. He also developed a dedicated interventional radiology clinic to support patients through complex procedures and expanded access to advanced services at the Scott Bieler Amherst Center. Dr. Petroziello's work continues to advance cancer treatment options while keeping patients at the center of every decision. Rohit Gosain, MD - Physician Excellence in Community Oncology Award Dr. Gosain, who completed fellowship training at Roswell Park, has dedicated his career to addressing disparities in cancer outcomes between rural and urban populations. He delivers advanced, evidence-based oncology care in community settings while also serving as a global educator through the OncBrothers platform, a widely used resource for oncology professionals. Through the national and international symposiums he organizes, Dr. Gosain expands access to cancer knowledge and expertise worldwide. Dr. Reid has been instrumental in developing comprehensive cancer screening and prevention programs, including the expansion of Roswell Park's lung cancer screening initiative into a coordinated system encompassing risk assessment, imaging, navigation and follow-up care. She also extended these models to additional cancer types and led pioneering research on immunotherapy approaches aimed at intercepting cancer before it develops. Her work exemplifies the impact of translational research by ensuring discoveries reach the patients who need them most. Bethany L. Burns, DO - David C. Hohn Award for Excellence in Quality and Safety As Acting Director of Clinical Chemistry and Laboratory Director at the Roswell Park Scott Bieler Amherst Center, Dr. Burns successfully led major modernization efforts, including the implementation of new chemistry instrumentation and an institution-wide transition to a new point-of-care glucose testing platform. Both initiatives were completed without disrupting patient testing services, while strengthening communication and collaboration among laboratory, nursing, information technology and clinical teams. Ian Lund, PA - Advanced Practice Provider Excellence Award Since joining Roswell Park as an advanced practice provider student in 2010, Lund has become a trusted expert in the care of patients with multiple myeloma and other hematologic malignancies. In addition to managing a full clinical workload, he has played a critical role in orienting, training and mentoring new advanced practice providers, helping to strengthen the next generation of cancer care professionals. Since joining Roswell Park in 2017, Dr. Fountzilas has worked closely with laboratory scientists to develop new treatment approaches for gastrointestinal cancers. His partnership with researchers led to the launch of an innovative clinical trial based on discoveries involving DNA repair mechanisms in aggressive "p53-mutant" cancers. The work earned a prestigious National Institutes of Health MERIT Award and has opened promising new therapeutic opportunities for patients facing some of the most challenging cancer diagnoses. The annual Excellence Awards highlight the extraordinary achievements of Roswell Park team members whose work advances the organization's mission to eliminate cancer through discovery-driven care that brings hope and cures. From the world's first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide. The Roswell Park team of 4,000+ makes compassionate, patient-centered cancer care and services accessible across New York State and beyond. Rated "Exceptional" by the National Cancer Institute, Roswell Park, founded in 1898, was one of the first NCI-designated comprehensive cancer centers in the country and remains the only one in Upstate New York. To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit www.roswellpark.org, call 1-800-ROSWELL (1-800-767-9355) or email [email protected]. Media Contact
Roswell Park unveils new EDDY unit to expand access to Lung Cancer Screening and Early Detection. Monday, September 14, 2026 - 03:00 pm New vehicle will bring lifesaving screenings to more neighborhoods, community centers and underserved communities Highlights * More compact unit can navigate narrow streets and smaller parking lots * Over 3,400 lung cancer screenings performed since program launched in 2022 * EDDY program includes a second vehicle for breast and prostate screening BUFFALO, N.Y. - Roswell Park Comprehensive Cancer Center has unveiled a new and more compact mobile lung cancer screening unit, expanding the reach of its Early Detection Driven to You (EDDY) mobile cancer screening program and increasing access to lifesaving cancer screenings throughout Western New York. The new EDDY Mobile Lung Cancer Screening Center, which replaces a vehicle in service since 2022, was engineered for flexibility, allowing it to travel more easily on city streets and operate in community center parking lots, neighborhood gathering spaces and other locations where larger vehicles may be difficult to accommodate. Supported by Roswell Park team members specially trained in Diagnostic Imaging, Cancer Screening and Survivorship, and Community Outreach and Engagement, the EDDY Mobile Cancer Screening Program brings high-quality screening services directly into communities across Western New York. Together with the EDDY Mobile Breast & Prostate Cancer Screening Center debuted last year, this innovative Roswell Park screening program is the first initiative to bring early detection services for the three most common invasive cancers directly into urban and rural communities where screening access may be limited. "Our new EDDY Mobile Lung Cancer Screening Center was designed very intentionally to increase the reach of our incredible outreach and early detection services," said Candace Johnson, PhD, President, CEO and M&T Bank Presidential Chair in Leadership at Roswell Park. "The streamlined design allows us to bring lung cancer screenings to even more neighborhoods, community centers and types of locations making it easier for more people to access potentially lifesaving care." "Screening gives us the opportunity to find lung cancer before symptoms develop, when treatment is often most effective and outcomes can be significantly improved," says Mary Reid, PhD, Chief of Cancer Screening, Survivorship and Mentorship. "This beautiful new mobile screening center will help us reach more individuals in more communities and connect them with potentially lifesaving early detection services. Every screening represents an opportunity to find cancer earlier, intervene sooner and ultimately save lives." Roswell Park held a ribbon-cutting Monday as it unveiled the new mobile unit at the Belle Center on Buffalo's West Side - one of the community centers that has frequently hosted the EDDY Lung and EDDY Breast and Prostate mobile screening centers to make this service available to those it serves. "It is such an honor to work with Roswell Park Comprehensive Cancer Center. It's not only the number one cancer research center in the nation, in my opinion, it's also number one in community service," says Lucy Candelario, Executive Director of the Belle Center. Since launching in 2022, the EDDY Mobile Lung Cancer Screening Center has completed more than 3,400 early detection encounters, reaching patients from 173 ZIP codes. The unit has visited 72 unique locations across 7 counties, including Erie, Cattaraugus, Chautauqua, Allegany, Niagara, Orleans and Broome. Operating 4 days per week in the community, it has partnerships with the Cattaraugus, Tonawanda and Tuscarora tribal territories. It also conducts screenings with 6 fire departments to address occupational exposure risks. More than two dozen screening participants were diagnosed with lung cancer through EDDY screenings, the majority of which were detected at early, more treatable stages. Speaking in Spanish at the event Monday, Evelyn Centeno, a survivor of a previous experience with cancer who has used EDDY mobile cancer screening services three times, said: "Para mí significó mucho que EDDY llegara cerca de mi hogar, a lugares que conocemos en la comunidad. Cuando estos servicios llegan directamente a la comunidad, hacen la vida más fácil para muchas personas. No todo el mundo tiene transportación, puede viajar lejos o puede tomar tanto tiempo fuera del trabajo o de la familia. Por eso, tener a EDDY ahí mismo, cerca de nosotros, ayuda muchísimo." (Translation: "It meant so much to me that EDDY came close to my home, to places we know in the community. When these services come directly into the community, they make life easier for many people. Not everyone has transportation, can travel far, or can take extra time away from work or family. That is why having EDDY right there, close to us, helps so much.") "Roswell Park's expansion of the EDDY program will continue to save lives by bringing screening to more neighborhoods and underserved communities, removing barriers to care and allowing Western New Yorkers to take control of their health," says Congressman Tim Kennedy. "I am grateful for the work and advocacy of everyone at Roswell Park. Their commitment to bringing lifesaving cancer screenings directly into our communities is making a real difference across our region." "Too many families in our community have felt the impact of cancer, which is why programs like EDDY are so incredibly important," says New York State Assemblymember Jon D. Rivera. "By bringing lung cancer screenings directly into neighborhoods, community centers, and underserved areas, Roswell Park is breaking down barriers to care and helping people get screened before it's too late. This new mobile unit reflects Roswell Park's longstanding commitment to innovation and community outreach. I thank Dr. Candace Johnson and the entire Roswell Park team for ensuring that Western New Yorkers have access to the early detection services they need to live healthier lives." Also on hand for the launch event were representatives from USA Mobile Medical, which manufactured the custom 53-foot mobile unit for Roswell Park, and Philips, manufacturer of the specialized low-dose CT (computed tomography) imaging equipment housed in the new mobile screening center - a CT 5300 system equipped with AI-enabled imaging, advanced workflow technologies and AI-based image reconstruction innovation designed to support high quality, low-dose CT imaging. Facts about lung cancer and lung cancer screening: * Lung cancer is the leading cause of cancer deaths in both men and women, causing more deaths than colorectal cancer, pancreatic cancer and breast cancer combined. * Only 24% of these tumors are diagnosed at early stages, when treatment options and expected survival are much more favorable. * Black Americans have a higher risk of developing lung cancer and are 18% less likely than their white counterparts to be diagnosed early. * Based on compelling evidence from large national studies, the U.S. Preventive Services Task Force recommends annual low-dose computed tomography (CT) lung scans for people ages 50-80 who have smoked for at least 20 years. * Earlier this year, the Centers for Medicare & Medicaid Services (CMS) announced a national coverage determination (NCD) that expanded coverage for lung cancer screening to improve health outcomes for people with lung cancer. * More than 36% of New York State residents living in counties with the highest rates of lung cancer deaths must drive at least an hour to get a low-dose CT scan. * Eligibility: You should be screened for lung cancer if you are within the ages of 50 and 79 and have 20 pack/years of smoking history and have smoked within the past 15 years, even if you no longer smoke. You may also be eligible based on personal history of cancer of the lung, esophagus, head or neck, or other factors, including: asbestos-related lung disease or pulmonary asbestosis; history of emphysema; chronic obstructive pulmonary disease (COPD); family history of lung cancer (your parent, sibling or child). * Roswell Park has offered lung cancer screening since 1998 for people who are at high risk of developing the disease. From the world's first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide. The Roswell Park team of 4,000+ makes compassionate, patient-centered cancer care and services accessible across New York State and beyond. Rated "Exceptional" by the National Cancer Institute, Roswell Park, founded in 1898, was one of the first NCI-designated comprehensive cancer centers in the country and remains the only one in Upstate New York. To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit www.roswellpark.org, call 1-800-ROSWELL (1-800-767-9355) or email [email protected]. Media Contact
Roswell Park's recognition: implications for cancer care and research. August 15, 2026 Recently, Roswell Park Comprehensive Cancer Center was honored by Forbes as one of the best employers for women and one of the best in-state employers. This prestigious recognition highlights not only the quality of the workplace environment but also the potential impact on patient care and cancer research. In a field as complex and challenging as oncology, the well-being of healthcare professionals can directly influence the quality of care that patients receive. In this blog post, Cure Cancer With AI will explore the significance of such recognition for cancer patients and the broader implications for the research community. What happened. Forbes evaluated numerous organizations to compile its list of top workplaces, focusing on employee satisfaction, support, and overall happiness. Roswell Park's inclusion in these lists signifies a commitment to cultivating a positive work culture, which is paramount in a high-stress environment like cancer care. A supportive workplace can lead to better collaboration among staff, improved patient interactions, and ultimately, enhanced treatment outcomes. Background: the importance of employee satisfaction in cancer care. The connection between employee satisfaction and patient care is well-documented. When healthcare professionals feel valued and supported, they are more likely to go above and beyond for their patients. In the context of cancer treatment, this can translate to greater attentiveness, empathy, and a holistic approach to patient care. For patients and their families, knowing that the staff at a cancer center is content can foster trust and confidence in the care they will receive. Roswell Park's achievement serves as a reminder that the overall atmosphere within a healthcare facility can significantly affect the patient experience. A positive work culture not only enhances staff morale but also contributes to a more patient-centered approach to care. When healthcare teams work cohesively and supportively, it can lead to better health outcomes, particularly in oncology, where treatment regimens are often complex and multifaceted. How AI fits into cancer research and the path toward better treatments. Artificial intelligence (AI) and machine learning are revolutionizing cancer research and treatment, offering unprecedented opportunities to enhance patient care. While Roswell Park's recognition focuses on employee satisfaction, it also highlights the importance of an environment conducive to innovation. The integration of AI in oncology can lead to more effective diagnostics, personalized treatment plans, and accelerated drug discovery processes. The role of AI in diagnostics. AI technologies are being used to analyze medical imaging and pathology reports more efficiently than traditional methods. By identifying patterns that humans might miss, AI can assist healthcare professionals in making quicker and more accurate diagnoses. This rapid identification is crucial in oncology, where early detection can significantly influence treatment efficacy. Machine learning in drug discovery. In drug discovery, machine learning algorithms can analyze vast datasets to identify potential therapeutic targets and predict how different compounds might behave in the human body. This approach not only speeds up the development of new cancer treatments but also helps researchers understand which patients are likely to benefit from specific therapies, paving the way for precision oncology. AI-Driven patient management. AI is also transforming how healthcare systems manage cancer patients. From tracking treatment progress to predicting patient outcomes, AI tools can enhance the overall patient experience. For instance, predictive analytics can help healthcare providers identify which patients might need additional support, ensuring that care is tailored to individual needs. What patients and readers should know. For cancer patients and their families, understanding the implications of workplace satisfaction at cancer centers like Roswell Park is vital. A supportive environment for healthcare providers can lead to improved patient care, which is essential in the context of cancer treatment. As patients navigate their journeys, knowing that they are being cared for by satisfied and engaged professionals can offer peace of mind. Furthermore, staying informed about advancements in cancer research and the role of AI can empower patients and their families. Resources like curecancerwithai.com provide a centralized platform for exploring how artificial intelligence is being used in oncology, keeping patients and advocates updated on the latest news and developments in cancer research. This knowledge can help families make more informed decisions about their care and understand the potential benefits of emerging treatments. Conclusion. The recognition of Roswell Park as one of the best employers underscores the importance of a supportive workplace in the field of oncology. As cancer treatment continues to evolve with the integration of artificial intelligence and machine learning, the implications for patient care are profound. By fostering an environment where healthcare professionals feel valued, Cure Cancer With AI can ensure that patients receive the highest standard of care. For those interested in learning more about how AI is transforming cancer research and treatment, curecancerwithai.com offers valuable insights and resources to stay informed.